Press Releases | DEA.gov
Pasar al contenido principal
U.S. flag

Un sitio oficial del Gobierno de Estados Unidos

Así es como usted puede verificarlo

Dot gov
Los sitios web oficiales usan .gov
Un sitio web .gov pertenece a una organización oficial del Gobierno de Estados Unidos.
Https

Los sitios web seguros .gov usan HTTPS
Un candado ( Candado Un candado cerrado ) o https:// significa que usted se conectó de forma segura a un sitio web .gov. Comparta información sensible sólo en sitios web oficiales y seguros.

  • Quiénes somos
    • Sobre la DEA
    • Mission
    • Leadership
    • Nuestra historia
    • Divisiones Nacionales
      • Operational Divisions
    • DEA Museum
    • Wall of Honor
    • Contáctenos
      • Submit a Tip
      • Extortion Scam
      • Public Affairs
      • Social Media Directory
  • Recursos
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Ley de Libertad de Información
      • Fee Waiver
    • Publications
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas
      • Human Trafficking Prevention

United States Drug Enforcement Administration

  • Recibir Actualizaciones
  • Scam Alert
  • Menú Completo
  • English
  • Español

Main Menu

Explore DEA
  • Quiénes somos
    • Sobre la DEA
    • Mission
    • Leadership
    • Nuestra historia
    • Divisiones Nacionales
    • DEA Museum
    • Wall of Honor
    • Contáctenos
  • Recursos
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Ley de Libertad de Información
    • Publications
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas

Press Releases

Advanced Search

Enter Keywords Below

Filter Results

Select To Narrow Search Results

Year

  • 2025 (6)
  • 2024 (1)
  • 2023 (4)
  • 2022 (1)
  • 2020 (2)

Subject

  • Drug Trafficking (594)
  • Guns/Weapons (144)
  • Synthetic drugs (116)
  • Guilty Plea (62)
  • Arrests/Convictions - Major (51)
  • Prescription Drugs (51)
  • Fake Pills (49)
  • OCDETF/Task Force (44)
  • Pharmaceuticals/Pharmacists/Physicians (39)
  • Money Laundering (38)
  • Overdose (38)
  • Seizures (Drugs/Property) (28)
  • Major Law Enforcement Operation (27)
  • Gangs (17)
  • Take Back Day (16)
  • Outreach/Drug Prevention (12)
  • Fentanyl Awareness (9)
  • Dark Web- Internet Trafficking (7)
  • Extraditions (6)
  • Fentanyl Free America (5)
  • Task Forces/Task Force Officers (4)
  • Asset Forfeiture (3)
  • One Pill Can Kill (3)
  • Prevention/Education - DEA websites GSAD, JTT etc (3)
  • Campaigns (2)
  • Narcoterrorism (2)
  • Congressional Affairs (1)
  • Counterfeit Pills (1)
  • Critical Incident (1)
  • HIDTA (1)
  • Press Conferences (1)
  • Public and Media Affairs - also see Congressional Affairs (1)
  • Terrorism (1)
  • Diversion Division (14)

Drug Name

  • Heroin (1)
  • Opioids (1)
  • Oxycodone (1)

Field Division

  • New England (35)
  • Washington, DC (34)
  • Seattle (25)
  • New York (23)
  • Chicago (18)
  • Houston (16)
  • New Jersey (14)
  • Atlanta (13)
  • Miami (10)
  • Sede (10)
  • New Orleans (8)
  • El Paso (7)
  • Dallas (5)
  • Rocky Mountain (5)
  • Phoenix (4)
  • Los Angeles (3)
  • Omaha (3)
  • San Diego (3)
  • Louisville (2)
  • Detroit (1)
  • San Francisco (7)
  • St. Louis (7)
Clear All Results
14 Results - Showing 1 to 10
PRESS RELEASE

Digital Health Company Cofounder/CEO and Clinical President Convicted in $100M Adderall Distribution and Health Care Fraud Scheme

SAN FRANCISCO – United States Drug Enforcement Administration (“DEA”) San Francisco Division Special Agent in Charge Bob Beris, DEA New York Division Special Agent in Charge Frank Tarentino, along with our law enforcement partners Homeland Security Investigations (“HSI”) , U.S. Department of Health and Human Services – Office of Inspector...
PRESS RELEASE

Communities Nationwide Join DEA and its Partners to Safely Dispose of 571,000 pounds of Unwanted Medications

SAN FRANCISCO – On October 25, 2025, DEA joined 4,263 law enforcement agencies across the country who came together for the 29th National Prescription Drug Take Back Day. At 4,317 collection sites nationwide, Take Back events removed 571,054 pounds of unneeded and expired medications from home medicine cabinets to prevent...
PRESS RELEASE

Owner of Kansas City, Kansas Pharmacy Agrees to Pay $200,000 to Resolve Allegations of Violating the Controlled Substances Act

KANSAS CITY, KAN. – Daniel Reif, Inc., doing business as The Medicine Shoppe, a retail pharmacy in Kansas City, Kansas, entered into a civil settlement agreement with the federal government agreeing to pay $200,000 to resolve allegations the pharmacy violated the civil provisions of the Controlled Substances Act (CSA). The...
PRESS RELEASE

Sacramento Doctor Agrees to Pay $125,000 for Controlled Substances Act Violations at Sutter Imaging Capitol Pavilion

SACRAMENTO, Calif. — Philip Yen, M.D. has agreed to pay the United States $125,000 to resolve allegations that he failed to comply with federal statutory requirements related to his role as the Drug Enforcement Administration registrant at Sutter Imaging Capitol Pavilion, Acting U.S. Attorney Michele Beckwith and Drug Enforcement Administration...
PRESS RELEASE

DEA St. Louis Division Safely Disposes of More Than 33,000 Pounds of Unused Medications on 28th National Prescription Drug Take Back Day

ST. LOUIS – The Drug Enforcement Administration (DEA) St. Louis Division joined forces with law enforcement agencies across Kansas, Missouri and Southern Illinois to safely dispose of 33,840 pounds of unneeded and expired medications at the 28th National Prescription Drug Take Back Day, April 26. Nationally, more than 620,000 pounds...
PRESS RELEASE

Justice Department Sues Stockton-based Nurse Practitioner to Stop Her Sale of Illegal Opioid Prescriptions

SACRAMENTO, Calif. — The United States has filed a civil complaint against nurse practitioner Joan Rubinger, registered in Stockton, that alleges a long-running nationwide scheme to sell illegal opioid prescriptions for cash, Acting U.S. Attorney Michele Beckwith and Drug Enforcement Administration Special Agent in Charge Bob P. Beris announced. The...
PRESS RELEASE

Jefferson County Doctor, Staffers Accused of Conspiracy, Health Care Fraud

ST. LOUIS – A doctor with an office in St. Louis and two employees have been indicted in U.S. District Court and accused of illegally prescribing controlled substances and health care fraud. Dr. David A. Parks, 66, James M. Bilderback, 58, both of Jefferson County, Missouri, and Michelle J. Scheer...
PRESS RELEASE

Pharmacy Agrees to Pay $250,000 for Improperly Distributing Prescriptions

KANSAS CITY, Kan. - A Kansas City, Kansas, company entered into a civil settlement agreement with the federal government to pay $250,000 to resolve allegations that a retail pharmacy it owns violated the civil provisions of the Controlled Substances Act. Four B. Corporation, doing business as Balls Food Stores, owns...
PRESS RELEASE

CA Attorney General Bonta Announces Arrest of Santa Clara Doctor for Illegal Opioid Prescription Scheme

SANTA CLARA, Calif. — California Attorney General Rob Bonta today announced the arrest of and filing of charges against Dr. Arash Padidar, a Santa Clara County doctor accused of illegally prescribing opioids to patients. The arrest and charges are the result of an investigation into an alleged two-years-long illegal prescription...
PRESS RELEASE

Former Modesto Doctor Pleads Guilty to Illegally Prescribing Opioids

FRESNO, Calif. — Sawtantra Chopra, 76, of Modesto, pleaded guilty Wednesday to three counts of illegally prescribing opioids and other medication, U.S. Attorney Phillip A. Talbert and Drug Enforcement Administration Special Agent in Charge Brian M. Clark announced. According to court documents, Chopra admitted prescribing drugs — including hydrocodone, alprazolam...

Paginación

  • Current page 1
  • Page 2
  • Siguiente
  • Última página »
  • Quienes Somos
    • Sobre
    • Contáctenos
    • Museo DEA
  • Recursos
    • Ley de Libertad de Información (FOIA)
    • Publicaciones
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas
  • Políticas
    • Accesibilidad, Complementos y Política
    • Políticas Legales y Descargos de Responsabilidad
    • Antidiscriminación y Represalias Acto
    • Política de Privacidad
    • Política de Igualdad de Oportunidades en el Empleo del U.S. DOJ
    • USA.gov
    • Protección de Denunciantes
    • Your Rights as a Federal Employee

United States Drug Enforcement Administration

DEA.gov is an official site of the U.S. Department of Justice
Facebook X LinkedIn Instagram

DEA Contact Center

(202) 307-1000
Contact the Webmaster